Anti-microRNAs are possible new therapeutic target for type 2 diabetes

(Mary Ann Liebert, Inc./Genetic Engineering News) Researchers have shown that targeted silencing of microRNA-132, which is over-expressed in type 2 diabetes, can result in improved insulin secretion and reduced blood glucose in mice and increased insulin secretion in isolated human islet cells.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news